Author | Year | Type of study | Ref. method | Study participants | Setting | Sample size | Unit used | Excluded TG > 400 mg/dl |
---|---|---|---|---|---|---|---|---|
Atabi et al. | 2020 | Comparative study | Direct methods in which blocking agents inhibit lipoproteins other than LDL | General adult workers | Iran | 500 | mg/dl | Yes |
Chaen et al. | 2016 | Validation study | Selective solubilization method | Type 2 diabetics | Japan | 1828 | mg/dl | Yes |
Chen et al. | 2010 | New tool | Not specified | Out patients | China | 2180 | mg/dl | No |
Choi et al. | 2021 | Validation study | Enzymatic method | Korean adults | South Korea | 8250 | mg/dl | No |
Chung et al. | 2018 | Validation study | Not specified | Patients with coronary artery calcium score (CACS) ≥ 300 | South Korea | 299 | mg/dl | Yes |
Dansethakul et al. | 2015 | New tool | Homogenous enzymatic method | Residents of urban Thailand visiting for annual medical check-ups | Thailand | 1786 | mg/dl | No |
Ephraim et al. | 2018 | Comparative study | Enzymatic method | Patients with no evidence of metabolic disease visiting laboratory in Ghana | Ghana | 1518 | mmol/l | Yes |
Ferrinho et al. | 2021 | Comparative study | Direct colorimetric method | General Portuguese population | Portugal | 1689 | mg/dl | Yes |
Gasko et al. | 2006 | Validation study | Not specified | Brazilian adult population | Brazil | 10,000 | both | No |
Ghasemi et al. | 2018 | Validation study | Direct enzymatic method | General | Iran | 4750 | mg/dl | Yes |
Kang et al. | 2017 | Comparative study | Enzymatic method | Koreans | South Korea | 4270 | mg/dl | yes |
Karkhaneh et al. | 2019 | Comparative study | Enzymatic colorimetric assay | People from Tehran city | Iran | 2752 | mmol/l | No |
Lee et al.* | 2016 | Validation study | Enzymatic homogeneous assay | Korean adults | South Korea | 5790 | mg/dl | No |
MartĂnez-Morillo et al. | 2021 | Comparative study | Enzymatic colorimetric assay | Â | Spain | 6113 | mmol/l | No |
Molavi et al. | 2020 | Comparative study | Enzymatic method | Iranian children and adolescent | Iran | 3844 | mg/dl | No |
Pradhan et al. | 2020 | Validation study | Enzymatic method | Â | Nepal | 538 | mg/dl | No |
Razi et al. | 2017 | Comparative study | Enzymatic photometric method | Type 2 diabetics | Iran | 1721 | mg/dl | No |
Rim et al. | 2016 | Comparative study | Enzymatic method | General adult patients | South Korea | 168,316 | mg/dl | Yes |
Sajja et al.* | 2021 | Comparative study | VAP, a rapid ultracentrifugation technique | General | USA | 111,939 | mg/dl | No, all cases have TG > 400 |
Sampson et al. | 2020 | Validation study | Î’-quantification | Not specified | Not specified | 8656 | mg/dl | No |
Singh et al. | 2020 | Validation study | Not specified | New York residents | USA | 10,936 | mg/dl | No |
Song et al. | 2021 | Comparative study | Homogeneous direct assay | Asymptomatic Korean adults | South Korea | 177,111 | mg/dl | No |
Sonoda et al. | 2018 | Validation study | Selective solubilization method | Japanese cardiovascular disease patients treated with statin | Japan | 385 | mg/dl | No |
Sonsok et al. | 2020 | Comparative study | Homogenous direct enzymatic assay | Residents of Nadun district | Thailand | 32,258 | mmol/l | No |
Vujovic et al.* | 2010 | Validation study | Enzymatic colorimetric assay | Patients visiting for routine checkup | Serbia | 1043 | mmol/L | No |